Journal
Clinical journal of the American Society of Nephrology : CJASN
Record source
PubMed Research Library
Abstract / Description
Government-led dialysis programs in most countries primarily focus on quality and safety measures for dialysis initiation and management. However, in the United States, CKD management may be shifting upstream of dialysis initiation toward value-based care models that prioritize delaying dialysis initiation and improving outcomes for patients with advanced CKD (stages 4 and 5 CKD). Nutritional interventions, particularly low and very low protein diets supplemented with keto-analogues of amino acids, are re-emerging as key strategies to reduce nitrogenous waste production, manage uremia, and slow CKD progression without causing malnutrition. Indeed, supplemented diets can help correct protein-energy wasting. Clinical trials and meta-analyses suggest that these diets can prolong dialysis-free periods and improve quality of life, although patient adherence and careful monitoring are crucial. This approach maintains nutritional status, while adjunct therapies, such as blood pressure control, volume management with diuretics, improved glycemic control, and anemia treatment with new oral medications, can manage comorbidities effectively without dialysis. Patients on such dietary regimens and their care partners often experience fewer unpleasant symptoms, greater satisfaction, and reduced transportation burdens. Unlike disease progression pharmacotherapies that are frequently associated with hyperkalemia, acute kidney injury, infections, and weight loss in very low kidney function (